Study Detail

TitlePrognostic factors of stable remission after cessation of TKI therapy in chronic myeloid leukemia by whole exome sequencing
Study TypePopulation Genomics
Abstract Chronic myeloid leukemia can be well controlled by targeted tyrosine kinase inhibitors (TKI). In some patients it is possible to terminate expensive and toxic long-life therapy, however about 50% of these patients relapse without treatment. In our study we found promissing new potential early progno .. [more]
Description Chronic myeloid leukemia can be well controlled by targeted tyrosine kinase inhibitors (TKI). In some patients it is possible to terminate expensive and toxic long-life therapy, however about 50% of these patients relapse without treatment. In our study we found promissing new potential early progno .. [more]
Center NameFederal State Budgetary Institution Ā«Research Centre For Medical GeneticsĀ», Moscow, Russia